BACE1 partial deletion induces synaptic plasticity deficit in adult mice

BACE1 is the first enzyme involved in APP processing, thus it is a strong therapeutic target candidate for Alzheimer’s disease. The observation of deleterious phenotypes in BACE1 Knock-out (KO) mouse models (germline and conditional) raised some concerns on the safety and tolerability of BACE1 inhib...

Descripción completa

Detalles Bibliográficos
Autores principales: Lombardo, Sylvia, Chiacchiaretta, Martina, Tarr, Andrew, Kim, WonHee, Cao, Tingyi, Sigal, Griffin, Rosahl, Thomas W., Xia, Weiming, Haydon, Philip G., Kennedy, Matthew E., Tesco, Giuseppina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934620/
https://www.ncbi.nlm.nih.gov/pubmed/31882662
http://dx.doi.org/10.1038/s41598-019-56329-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6934620/
https://www.ncbi.nlm.nih.gov/pubmed/31882662
http://dx.doi.org/10.1038/s41598-019-56329-7

Ejemplares similares